Day 1 :
Keynote Forum
Yoshiaki Omura
New York Medical College, USA
Keynote: Non-invasive, early, diagnostic method of cancer from visible & invisible changes of organ representation areas of face and role of Human papillomavirusType 16, electromagnetic field & other cancer-promoting factors for genesis and effective treatment of cancer by combining 10 unique, beneficial effects of optimal doses of Vitamin D3 & EPA-DHA & manual stimulation of Thymus gland representation area which release significant amounts of Thymosin α1 & Thymosin β4
Time : 09:30-10:10
Biography:
Professor Yoshiaki Omura received Oncology Residency Training and a Doctor of Science Degree through research on Pharmaco-Electro Physiology of Single Cells in vivo and in vitro from Columbia University. He published over 250 articles and 7 books. He is currently Editor-in-Chief of Acupuncture and Electro-Therapeutics Research, International Journal of Integrated Medicine, and Executive Editor of Integrative Oncology. Using his new diagnostic method, which received US patent, he can non-invasively and rapidly measure many neurotransmitters, chemicals, asbestos, viruses, and bacteria. He developed a non-invasive, quick diagnostic method of malignancies, as well as a method of evaluating the effects of any treatment.
Abstract:
Keynote Forum
Mohammed Naeem
King Abdullah Specialized Children’s Hospital, Saudi Arabia
Keynote: Critical care management of pediatric oncologic patients: To cure and to care
Time : 11:10-11:50
Biography:
Mohammed Naeem MD, FAAP, FCCP has vast interests and experience in care and development of children and adolescents. His passion gears towards constructing and implementing scientific models to improve systems targeting primary, secondary and tertiary care. His ideology takes a positive direction through his in-depth analyses and vision and further to explore multiple ways that would help understand the complex pathological phenomenon and planning to design and implement strategies to overcome these. His particular interest and expertise involves population of children and adolescents requiring intensive care. He had been utilizing his vast experience of research, clinical care, patient safety and strategic planning to ambitiously achieve his goals. Through multiple levels of participation in care and strategic planning relevant to diverse patient population, he had been very successful to make his contributions and judgments being heard and taken in considerations.
Abstract:
Aim: The scholarly activity shall present critical care aspects for the management of pediatric oncologic patients. Background: Over the last several years, there had been wide advancements in the Radiological diagnosis and overall management of pediatric oncologic patients. This emphasizes the need to have in-depth knowledge communication among various teams involved in the care of the pediatric oncologic patients. In terms of critical management, there are two broad dimensions for pediatric oncologic patients. First, to provide cure of the treatable conditions to pediatric oncologic patients apart from the underlying diagnosis. This includes respiratory failure, cardiac failure, sepsis, renal failure, neurologic critical care, metabolic derangements, post-human stem cell transplant, after toxic treatments, after cardiac arrest. Secondly, to provide care to pediatric oncologic patients if the underlying condition is not curable for example whether the patient needs palliative care or hospice care, what would be a most appropriate setting to manage the patients and other relevant issues. Conclusion: This activity targets to bridge knowledge gaps and to bring various teams involved in the care of pediatric oncologic patients at the same basic awareness. At the end of this activity, the participants shall have wide knowledge about the critical situations encountered in the care of pediatric oncologic patients and to learn the ways to overcome the wide range of situations through available diagnostic modalities, management options, and psychosocial techniques
Keynote Forum
Ehab Mohammed
Board certified Naturopathic Doctor, Canada
Keynote: Improved liver function after high dose intravenous vitamin C and Helxior SC injections in a patient with hepatocellular carcinoma progressed after chemotherapy and radiation
Time : 11:00-11:50
Biography:
Ehab Mohammed has completed his Medical School degree from Cairo University, Egypt, had residency training in Medical and Radiation Oncology, published 36 clinical peer reviewed articles in medical and radiation oncology. Practiced oncology for 20 years in Egypt, ad promoted to a professor of clinical oncology in Cairo University, Egypt 2009. In Canada, Dr Ehab changed his career to Naturopathic Medicine and practcing mainly Oncology Naturopathy for cancer patients. He is a board certified Naturopathic Doctor and practice in Toronto and Grimsby Ontario.
Abstract:
Keynote Forum
Zhiwen Zhang
First Affiliated Hospital of Chinese General Hospital, China
Keynote: The effectiveness of stereotactic radiosurgery and bevacizumab for recurrent high-grade gliomas
Time : 12:00-12:40
Biography:
Zhiwen Zhang, MD, PhD, director of Department of Neurosurgery, First Affiliated Hospital of Chinese General Hospital. He has completed his MD and PhD in China, worked in Kyoto University as visiting professor for 4 years. He has published more than 25 papers in reputed journals and has been serving as an editorial board member of repute
Abstract:
- Cancer Therapy | Cancer Imaging | Nuclear Medicine | Radiology Imaging | Proton Theray Nuclear Medicine | Paediatric Oncology | Computer Assisted Tomography | Ultrasound Imaging | Musculoskeletal
Session Introduction
Mosa Alhamami
University of Toronto, Canada
Title: Manganese-enhanced magnetic resonance imaging of breast cancer cells
Biography:
Abstract:
There has been continued interest in engineering MRI contrast agents (CAs) and evaluating their diagnostic efficacy to overcome issues associated with clinically-approved CAs such as Gd-DTPA. Of particular interest are intracellular CAs that can provide sensitive identification of labelled cells, opening the possibility of directly detecting early changes driving cancers at the cellular level before vasculature has been fully formed. To further explore the capabilities of intracellular CAs in T1-weighted MRI of breast cancer, this work aimed at (1) demonstrating the potential of MnCl2-enhanced MRI to detect and characterize early small breast tumors in vivo (2) investigating the potential of manganese-porphyrin-enhanced MRI for sensitive detection of multiple clinical subtypes of breast cancer cells (3) utilizing quantitative MRI to demonstrate the role the balance between hydrophilicity and hydrophobicity plays in developing CAs for effective T1-weighted MRI of cancer. This work has shown that MnCl2, unlike Gd-DTPA, provided enhancement of the entire tumor mass, depicting both tumor borders and interior morphology. At the early stage of tumor growth, MnCl2 also enabled cancer subtype-dependent differential enhancement and characterization. Moreover, this work demonstrated the superior T1 enhancement capabilities of manganese porphyrins over Gd-DTPA of multiple clinical subtypes of breast cancer cells at 3.0T. Also, using quantitative MRI, the more hydrophobic manganese porphyrin, MnTPPS3NH2, is shown to be a more sensitive T1 CA than MnTPPS4 for cellular imaging of breast cancers. Such sensitive cellular detection can potentially lead to lowering the dose needed to achieve positive enhancement and merits further future in vivo investigation
Carlos Zepeda-Velázquez
Ontario Institute for Cancer Research,Canada
Title: The discovery and evaluation of OICR-9429: A small molecule antagonist of the Wdr5-Mll interaction
Biography:
Abstract:
At a fundamental level, gene expression is regulated by epigenetic histone modifications. Histone methyltransferases catalyze the transfer of the methyl group from S adenosylmethionine to specific lysine residues on histones. Mixed lineage leukemia 1 (MLL1) is a methyltransferase that methylates lysine 4 on histone H3 (H3K4me3) and is an important regulator of the haemopoietic system. Dysregulation of MLL1 is often associated with acute myeloid and lymphoid leukemias, making it an attractive therapeutic target. WD40 repeat protein 5 (WDR5) is a component of the multiprotein MLL1 complex that is essential for its methyltransferase activity, and disruption of the WDR5/MLL1 interaction may therefore present a viable therapeutic option for the treatment of MLL-dependent leukemias. Employing structure-based design principles and cheminformatic tools, compounds that bind to WDR5 with low nanomolar affinities were synthesized. Of the various small molecules assessed, OICR-9429 demonstrated the most potent activity with KD values of 51 nM (Biacore), 64 nM (FP) and 52 nM (ITC). OICR9429 also disrupts the interaction of WDR5 with MLL1 and RbBP5 in cells with IC50 values below 1 µM
Romina Geraldine D’Souza
Christian Medical College Hospital, India
Title: Can we tell? MRI parameters to predict occult lymph node metastasis in oral cavity malignancies
Biography:
Dr Romina Geraldine D’Souza, she had completed my MD Radiology from Father Muller Medical college Mangalore, India, Diplomate of the National Board in Radiology and currently doing a fellowship in Crossectional radiology in Christian Medical College, Vellore India and FRCR 2
Abstract:
Mohammed Naeem
King Abdullah Specialized Children’s Hospital, Saudi Arabia
Title: Approach to wide aspects of end of life care in children
Biography:
Mohammed Naeem MD, FAAP, FCCP has vast interests and experience in care and development of children and adolescents. His passion gears towards constructing and implementing scientific models to improve systems targeting primary, secondary and tertiary care. His ideology takes a positive direction through his in-depth analyses and vision and further to explore multiple ways that would help understand the complex pathological phenomenon and planning to design and implement strategies to overcome these. His particular interest and expertise involves population of children and adolescents requiring intensive care. He had been utilizing his vast experience of research, clinical care, patient safety and strategic planning to ambitiously achieve his goals. Through multiple levels of participation in care and strategic planning relevant to diverse patient population, he had been very successful to make his contributions and judgments being heard and taken in considerations
Abstract:
Yoshiaki Omura
New York Medical College, USA